Flagged for Manual Review

Round 3 merged 15 different OpenAlex profiles by name match alone (unverified)

Metrics shown are from the primary verified profile.15 name-matched profiles were discovered and excluded from these metrics.

Robert Thomas

Published as: Robert J. S. Thomas

Unknown, Unknown · RMSANZ Member (AFRM Trainees) · FAFRM

Institution(s): AU

MM 1 - Metropolitan(Postcode: 3010)

Cancer rehabilitationSurgery and perioperative careGenetics and molecular biologyCardiac & respiratory rehabilitationEpidemiology and public health

H-index

Publications

1,904

Citations

4.18

FWCI

Funding Awards

Clinical Trials

Publication Timeline

Click a bar to filter publications by year

Funding Awards (83)

Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study

Cancer Research UK · 2025(EDDAPA-2022/100002)

Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study

Cancer Research UK · 2025(C18081/A18180)

Chemotherapy use in ovarian cancer patients diagnosed 2012–2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study

Cancer Research UK · 2025(EDDAPA-2022/100002)

Chemotherapy use in ovarian cancer patients diagnosed 2012–2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study

Cancer Research UK · 2025(C18081/A18180)

Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

Medical Research Council · 2024(HDR-23012)

Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

Cancer Research UK · 2024(A18180)

Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

Cancer Research UK · 2024(C18081)

Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

Cancer Research UK · 2024(100002)

Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

Cancer Research UK · 2024(C18081/A18180)

Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

Medical Research Council · 2024(HDR-23012)

Identifiers & Metadata

Profile ID:A5078598590

Alt. IDs:

A5111572334

Confidence:REVIEW

Collaborators:0

Verification:Original REVIEW match not verified in Round 2 due to batch coverage. IDs retained pending manual review.

Publications (91 shown of 96 total)

Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study

BMJ Oncology · 2025 · 1 citations

Supplementary Table from Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's Esophagus

Figshare · 2025 · 0 citations

Supplementary Figure from Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's Esophagus

Figshare · 2025 · 0 citations

Data from Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's Esophagus

2025 · 0 citations

Supplementary Data from Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's Esophagus

Figshare · 2025 · 0 citations

Chemotherapy use in ovarian cancer patients diagnosed 2012–2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study

Cancer Epidemiology · 2025 · 0 citations

Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

The Lancet Oncology · 2024 · 20 citations

Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

The Lancet Oncology · 2024 · 18 citations

Enhancing inpatient chemo/immunotherapy stewardship: A novel scoring rubric approach to optimize utilization and reduce costs.

Journal of Clinical Oncology · 2024 · 0 citations

PD29-06 MENTAL WELLBEING IN PROSTATE CANCER: RESULTS FROM THE MULTI-CENTRE MIND-P COHORT STUDY

The Journal of Urology · 2024 · 0 citations